Table VI.
All subjects | Males | Females | P-value* | |
---|---|---|---|---|
Definite AD + cam deformity | ||||
Definite AD + α angle ≥55° | 40% (4/10) | 40.0% (2/5) | 40.0% (2/5) | 1 |
[16.8%–68.7%] | [11.8%–76.9%] | [11.8%–76.9%] | ||
Definite AD + HNOR < 0.13 | 100% (10/10) | 100% (5/5) | 100% (5/5) | – |
[72.2%–100%] | [56.6%–100%] | [56.6%–100%] | ||
Definite AD + PGD positive | 10% (1/10) | 20% (1/5) | 0% (0/5) | 0.292 |
[1.8%–40.4%] | [3.6%–62.4%] | [0%–43.3%] | ||
Definite AD + HP positive | 20% (2/10) | 20% (1/5) | 20% (1/5) | 1 |
[5.7%–51.0%] | [3.6%–62.4%] | [3.6%–62.4%] | ||
Definite AD + pincer deformity | ||||
Definite AD + acetabular index ≤0° | 0% (0/2) | 0% (0/2) | (0/0) | – |
[0%–65.8%] | [0%–65.8%] | |||
Definite AD + RA | 100% (2/2) | 100% (2/2) | (0/0) | – |
[34.2%–100%] | [34.2%–100%] | |||
Borderline AD + cam deformity | ||||
Borderline AD + α angle ≥55° | 55.6% (10/18) | 41.7% (5/12) | 83.3% (5/6) | 0.094 |
[33.7%–75.4%] | [19.3%–68.0%] | [43.6%–97.0%] | ||
Borderline AD + HNOR < 0.13 | 88.9% (16/18) | 83.3% (10/12) | 100% (6/6) | 0.249 |
[67.2%–96.9%] | [55.2%–95.3%] | [61.0%–100%] | ||
Borderline AD + PGD positive | 27.8% (5/18) | 25.0% (3/12) | 33.3% (2/6) | 0.709 |
[12.5%–50.9%] | [8.9%–53.2%] | [9.7%–70.0%] | ||
Borderline AD + HP positive | 22.2% (4/18) | 33.3% (4/12) | 0% (0/6) | 0.109 |
[9.0%–45.2%] | [13.8%–60.9%] | [0%–39.0%] | ||
Borderline AD + pincer deformity | ||||
Borderline AD + acetabular index ≤0° | 33.3% (1/3) | 0% (0/2) | 100% (1/1) | 0.083 |
[6.1%–79.2%] | [0%–65.8%] | [20.7%–100%] | ||
Borderline AD + RA | 66.7% (2/3) | 100% (2/2) | 0% (0/1) | 0.083 |
[20.8%–93.9%] | [34.2%–100%] | [0%–79.3%] |
Data are shown as percentage [95% CI]. AD, acetabular dysplasia; FAI, femoroacetabular impingement; PGD, pistol grip deformity; HP, herniation pit; HNOR, head–neck offset ratio; RA, retroverted acetabulum.
Male versus female, evaluated with χ2 test. P-values of <0.05 were considered statistically significant.